secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0001493152-24-022945
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn Therapeutics reports conversion of $226,903 in debentures at $6.00 per share, issuing 37,820 shares.
--------------------------------------------------------------------------------

- Holders converted $226,903 of Original Issue Discount Senior Convertible Debentures at avg. exercise price of $6.00/share.
- Company issued 37,820 shares of common stock to debenture holders.
- Outstanding common shares increased from 1,225,833 to 1,263,653 as a result.
- Conversions occurred from May 30 to June 6, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315224022945/0001493152-24-022945-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315224022945/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-022945

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer